![](https://investorshub.advfn.com/uicon/750370.png?cb=1607199114)
Tuesday, June 14, 2022 11:16:31 PM
This is potentially big news for $RVVTF. Pfizer just stopped their trial for standard risk patients for Paxlovid for COVID treatment. The data showed no improvement. Door wide open for Revive to dominate the general pop market. 💯@danfaraci @RexWiggins12 https://t.co/Jv5MM669PT
— The Dales Report (@TheDalesReport) June 14, 2022
Ps. could possibly add a little more to market cap
pps. or a Lot more....
ppps. probably last year working for many of us... hopefully just invest, trade even some, from home.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM